United Airlines has found loose bolts on door plugs of several Boeing 737 Max 9 planes during inspections. The FAA on Saturday grounded dozens of 737 Max 9s after the panel blew out midflight on Alaska Flight 1282.
Each January, just about every corner of the industry shows up with announcements and previews that set the stage for the year to come.
Biden admin to announce independent contractor rule that could upend gig economy (more)
Treasury yields resume slide aided by oil and inflation outlook (more)
Oil prices drop as Saudi Arabia cuts prices (more)
Mortgage rate decline pulls buyers back into the housing market (more)
IPO investors hope the Fed is finally ready to restart the party (more)
French Prime Minister Borne resigns; replacement not yet named (more)
Nvidia rallies to record high as chipmaker announces AI-related components (more)
Apple Vision Pro goes on sale Feb 2 for $3,500 (more)
Apple iPhone sales in China fall 30% in first week of 2024 (more)
ChatGPT to be equipped in cars, starting with Volkswagen (more)
JetBlue CEOto step down as airline awaits judge’s ruling on Spirit Airlines merger (more)
Twilio co-founder Lawson steps down as CEO after bruising activist battles (more)
Blackstone’s first private equity fund for rich individuals gets $1.3 billion (more)
ESG campaigns seen falling out of favor with activist investors (more)
J&J, Merck and Boston Scientific go on $6.4 billion buying spree (more)
Chinese billionaire is second-biggest foreign owner of US land (more)
TOGETHER WITH TRADINGVIEW
Where the world charts, chats and trades.
Come see what everybody’s talking about! Try TradingView — the supercharged super-charting platform and social network for traders and investors. Free to sign up.
~ please suppor/t our sponsors ~
DEALFLOW
M & A | INVESTMENTS
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion (more)
Merck to acquire Harpoon Therapeutics, further diversifying oncology pipeline (more)
Boston Scientific announces agreement to acquire Axonics, Inc. (more)
Second Dinner, the game development studio behind the hit game MARVEL SNAP, raised $100M in Series B funding (more)
Claris Bio, a late-clinical stage biotechnology company, raised $57M in funding (more)
Care Continuity, a company specializing in data-driven patient navigation, raised $10M in funding (more)
CharatcterX, a provider of a decentralized AI social network, raised $2.8M in Seed funding at a $30M valuation (more)
Imbed Biosciences, a tissue engineering company developing advanced biomaterials for soft-tissue repair, received $10M in convertible debt financing (more)
Health In Her HUE, a provider of a digital health platform, raised $3M in funding (more)
Rincell Corporation, a chemistry battery cell manufacturer, raised $1.2M in Seed funding (more)
WellBe Senior Medical, an in-home value-based care provider, received an investment from CVS Health Ventures (more)
Affinity Learning, a compliance training solution provider, received an investment from O’Shaughnessy Ventures (more)
Goldman Sachs Asset Management raised $650M for its West Street Life Sciences I, representing the first fund in the firm’s Life Sciences Investing strategy (more)
📈 Try It: TradingView is the supercharged super-charting platform and social network for traders and investors. Free to sign up.
DAILY SHARES
Ramp Capital @RampCapitalLLC
Fed’s gotta raise next meeting
Jan 9, 2024
183 Likes 10 Retweets 11 Replies
Trung Phan @TrungTPhan
The Vision Pro is on sale February 2, which means we are about enter phase 4 of Apple’s Product Hype Cycle
Jan 8, 2024
121 Likes 5 Retweets 17 Replies
Ramp Capital @RampCapitalLLC
“The name of the company, Stanley. It is a cutting edge high tech firm out of the Midwest, awaiting imminent patent approval on the next generation of travel tumblers that have both huge military and civilian applications…”
Disclaimer: MarketBriefing is a news publisher. All statements and expressions herein are the sole opinions of the authors or paid advertisers. The information, tools, and material presented are provided for informational purposes only, are not financial advice, and are not to be used or considered as an offer to buy or sell securities; and the publisher does not guarantee their accuracy or reliability. Please conduct your own research and consult an independent financial adviser before making any investments. Neither the publisher nor any of its affiliates accepts any liability whatsoever for any direct or consequential loss howsoever arising, directly or indirectly, from any use of the information contained herein. Assets mentioned may be owned by members of the MarketBriefing team.
